Literature DB >> 15583538

The role of oral microbial colonization in ventilator-associated pneumonia.

Michael T Brennan1, Farah Bahrani-Mougeot, Philip C Fox, Thomas P Kennedy, Sam Hopkins, Richard C Boucher, Peter B Lockhart.   

Abstract

The present article reviews the association between microbial colonization of the oral cavity and the lungs in critically ill patients that develop ventilator-associated pneumonia (VAP) in the intensive care unit (ICU) setting. The risk factors and microorganisms associated with VAP are presented. The role of oral colonization of VAP-associated pathogens (VAP-AP) in the development of VAP is examined. We explore the potential factors involved in oral colonization of VAP-AP, which are atypical bacteria for the oral cavity. Strategies for the prevention or moderation of oral colonization of VAP-AP have had limited success. We need a deeper understanding of the pathophysiology of VAP in order to reduce the morbidity, mortality, and cost from this common complication in ICU medicine and surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15583538     DOI: 10.1016/j.tripleo.2004.06.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  10 in total

1.  Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia.

Authors:  Farah K Bahrani-Mougeot; Bruce J Paster; Shirley Coleman; Sara Barbuto; Michael T Brennan; Jenene Noll; Thomas Kennedy; Philip C Fox; Peter B Lockhart
Journal:  J Clin Microbiol       Date:  2007-02-14       Impact factor: 5.948

2.  Microbial investigations in throat swab and tracheal aspirate specimens are beneficial to predict the corresponding endotracheal tube biofilm flora among intubated neonates with ventilator-associated pneumonia.

Authors:  Yun Pan; Lizhong Du; Qing Ai; Sijie Song; Xiaoli Tang; Danping Zhu; Jialin Yu
Journal:  Exp Ther Med       Date:  2017-06-20       Impact factor: 2.447

3.  Nosocomial pneumonia in critically ill patients.

Authors:  Girish L Dandagi
Journal:  Lung India       Date:  2010-07

4.  Oral microbial and respiratory status of persons with mental retardation/intellectual and developmental disability: an observational cohort study.

Authors:  Catherine J Binkley; Gilbert S Haugh; Dinah H Kitchens; Debra L Wallace; Daniel I Sessler
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-09-12

5.  Molecular analysis of microbial communities in endotracheal tube biofilms.

Authors:  Scott Cairns; John Gilbert Thomas; Samuel James Hooper; Matthew Peter Wise; Paul John Frost; Melanie Julia Wilson; Michael Alexander Oxenham Lewis; David Wynne Williams
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

Review 6.  Gingival and plaque decontamination: can we take a bite out of VAP?

Authors:  Jatinder Somal; Joseph M Darby
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Ventilator associated pneumonia and infection control.

Authors:  Emine Alp; Andreas Voss
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-06       Impact factor: 3.944

8.  Fraser syndrome-oral manifestations and a dental care protocol.

Authors:  Talita Lopes de Oliveira; Giselle Rodrigues de Sant'Anna
Journal:  Case Rep Dent       Date:  2014-12-21

Review 9.  Can povidone iodine gargle/mouthrinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence-based update.

Authors:  Aditi Chopra; Karthik Sivaraman; Raghu Radhakrishnan; Dhanasekar Balakrishnan; Aparna Narayana
Journal:  Jpn Dent Sci Rev       Date:  2021-03-15

10.  Microbial investigation of biofilms recovered from endotracheal tubes using sonication in intensive care unit pediatric patients.

Authors:  Thiago de Oliveira Ferreira; Rafael Yoshio Koto; Gabriel Fialkovitz da Costa Leite; Giselle Burlamaqui Klautau; Stanley Nigro; Cely Barreto da Silva; Ana Paula Idalgo da Fonseca Souza; Marcelo Jenne Mimica; Regina Grigolli Cesar; Mauro José Costa Salles
Journal:  Braz J Infect Dis       Date:  2016-08-08       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.